InspireMD, Inc.

TEL AVIV, L3 How do I update this listing?

Inspiremd is based out of Tel Aviv. InspireMD, Inc., a medical device company, engages in the development and commercialization of stent platform technology in Israel. The company provides MGuard, a stent platform that offers embolic protection in stenting procedures by placing a micron mesh sleeve over a stent. It offers its products for use in patients with acute coronary syndromes, primarily acute myocardial infarction and saphenous vein graft coronary interventions. The company���s products include MGuard Coronary that comprises a mesh sleeve wrapped around a bare-metal stent; MGuard Prime, which include its mesh sleeve wrapped around a cobalt-chromium stent; and MGuard Coronary with a drug eluting mesh that provides bio-absorbability and uniform drug therapy management. It sells its products through distributors in Europe, Asia, and Latin America.Whalewisdom has at least 108 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2017-12-12. The notice included securities offered of Equity,Option, Warrant or Other Right to Acquire Another Security

Create Alert

Contact Info

inspiremd, inc.
4 MENORAT HAMAOR ST.
TEL AVIV L3    6744832

Business Phone: (888) 776-6804
SEC SIC CODE:
3841-SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2017-12-12 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security 750,000 750,000 0
2016-06-16 D BIOTECHNOLOGY Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security,Other 182,399 182,399 0
2016-03-28 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 609,500 609,500 0
2013-01-18 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 3,089,945 3,089,945 0
2012-11-02 D BIOTECHNOLOGY Equity 1,763,000 1,763,000 0
2012-10-18 D BIOTECHNOLOGY Equity,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 450,158 450,158 0
2012-10-01 D BIOTECHNOLOGY Option, Warrant or Other Right to Acquire Another Security INDEFINITE 0 INDEFINITE
2012-10-01 D BIOTECHNOLOGY Equity,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 408,606 408,606 0
2012-04-18 D OTHER Debt,Option, Warrant or Other Right to Acquire Another Security 11,000,000 11,000,000 0
2011-08-26 D OTHER Option, Warrant or Other Right to Acquire Another Security 212,000 212,000 0
2011-08-26 D OTHER Option, Warrant or Other Right to Acquire Another Security 4,000 4,000 0
2011-08-26 D OTHER Option, Warrant or Other Right to Acquire Another Security 30,000 30,000 0
2011-08-26 D OTHER Option, Warrant or Other Right to Acquire Another Security 1,500,000 1,500,000 0
2011-08-26 D OTHER Option, Warrant or Other Right to Acquire Another Security 67,000 67,000 0
2011-04-27 D OTHER Equity,Option, Warrant or Other Right to Acquire Another Security 10,000,000 425,000 9,575,000
2011-04-14 D OTHER Equity,Option, Warrant or Other Right to Acquire Another Security 8,041,000 8,041,000 0
2011-04-14 D OTHER Equity 6,527,998 6,527,998 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ALAN W. MILINAZZO subscription required
    EXECUTIVE OFFICER DIRECTOR
ASHER HOLZER subscription required
    EXECUTIVE OFFICER DIRECTOR
CAMPBELL ROGERS subscription required
    DIRECTOR
CRAIG SHORE subscription required
    EXECUTIVE OFFICER
ELI BAR subscription required
    EXECUTIVE OFFICER
EYAL WEINSTEIN subscription required
    DIRECTOR
ISAAC BLECH subscription required
    DIRECTOR
JAMES BARRY subscription required
    DIRECTOR
JAMES J. LOUGHLIN subscription required
    DIRECTOR
MICHAEL BERMAN subscription required
    DIRECTOR
OFIR PAZ subscription required
    EXECUTIVE OFFICER DIRECTOR
PAUL STUKA subscription required
    DIRECTOR
PAUL STUKE subscription required
    DIRECTOR
ROBERT RATINI subscription required
    EXECUTIVE OFFICER
SOL J BARER subscription required
    DIRECTOR
THOMAS KESTER subscription required
    DIRECTOR

Elevate your investments